FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.3300
-0.0139 (-4.04%)
At close: Jan 8, 2026, 4:00 PM EST
0.3234
-0.0066 (-2.00%)
After-hours: Jan 8, 2026, 7:46 PM EST
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $21.95 million as of January 8, 2026. Its market cap has decreased by -68.80% in one year.
Market Cap
21.95M
Enterprise Value
24.20M
1-Year Change
-68.80%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $21.95M, a decrease of -97.68%. That is a compound annual growth rate of -85.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 22.88M | 52.91% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 944.90B |
| Johnson & Johnson | 496.31B |
| AbbVie | 391.46B |
| UnitedHealth Group | 315.55B |
| AstraZeneca | 280.51B |
| Merck & Co. | 272.00B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |